相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes
Douglas F. Easton et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas
Socorro Maria Rodriguez-Pinilla et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Classification of missense variants of unknown significance in BRCA1 based on clinical and tumor information
A. Osorio et al.
HUMAN MUTATION (2007)
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
Paul K. Lovelock et al.
BREAST CANCER RESEARCH (2007)
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral
SV Tavtigian et al.
JOURNAL OF MEDICAL GENETICS (2006)
Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance
G Chenevix-Trench et al.
CANCER RESEARCH (2006)
Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource
GJ Mann et al.
BREAST CANCER RESEARCH (2006)
Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations
T Judkins et al.
CANCER RESEARCH (2005)
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype
SR Lakhani et al.
CLINICAL CANCER RESEARCH (2005)
The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer
WD Foulkes et al.
CANCER RESEARCH (2004)
Integrated evaluation of DNA sequence variants of unknown clinical significance:: Application to BRCA1 and BRCA2
DE Goldgar et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
WD Foulkes et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
A full-likelihood method for the evaluation of causality of sequence variants from family data
D Thompson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Full-length archaeal Rad51 structure and mutants: mechanisms for RAD51 assembly and control by BRCA2
DS Shin et al.
EMBO JOURNAL (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
The pathology of familial breast cancer:: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2
SR Lakhani et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population
W Hofmann et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
BRCA1 RING domain cancer-predisposing mutations - Structural consequences and effects on protein-protein interactions
PS Brzovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1
RS Williams et al.
NATURE STRUCTURAL BIOLOGY (2001)
Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families
T Peelen et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
